Inside the Inspectorate

Operational Transformation Programme – an Inspectorate view

Posted by: Michelle Yeomans, Posted on: 22 March 2018 - Categories: Inside the Inspectorate, Wider MHRA

This post provides some background information to the aims of the operational transformation programme and how the inspectorate is rising to the challenge.

An Inspector Calls: Part 2, GMP Short Notice and Unannounced Inspections cont

Posted by: Tracy Moore, Posted on: 9 January 2018 - Categories: Compliance matters, Good manufacturing practice, Inside the Inspectorate

Potential patient safety issues, serious breaches of GMP or suspected criminal activity frequently trigger short notice or unannounced inspections

Looking for a New Challenge in 2018?

Posted by: Mark Birse, Posted on: 21 December 2017 - Categories: Compliance matters, Good clinical practice, Good distribution practice, Good manufacturing practice, Good pharmacovigilance practice, Inside the Inspectorate, Wider MHRA

Whilst we progress our latest recruitment campaign for GMDP Inspectors, Ian Holloway reflects on 30 years of working for the Medicines Regulator.

MHRA Inspectorate Organogram

Posted by: Mark Birse, Posted on: 11 May 2017 - Categories: Inside the Inspectorate

We have today updated the sidebar of the MHRA Inspectorate Blog to provide access to the MHRA Inspectorate organogram.

Losing GSi – MHRA emails are changing

Posted by: Mark Birse, Posted on: 10 April 2017 - Categories: Inside the Inspectorate, Wider MHRA

From 10 April, we are removing .gsi from our email addresses. Technology has changed a lot since the introduction of the Government Secure Intranet (GSi) in 1996

Overview of compliance management escalation processes used by the GMP Inspectorate

Posted by: Alan Moon, Posted on: 6 February 2017 - Categories: Compliance matters, Events and symposia, Good distribution practice, Good manufacturing practice, Inside the Inspectorate

At the GMDP Symposium 2016, Andrew Hopkins and I gave a presentation about the Inspection Action Group (IAG) and Compliance Management Team (CMT), to highlight the systems and processes in place for when compliance issues are identified at manufacturing and …

Who inspects the Inspectors? (Part II)

Posted by: Ian Jackson, Posted on: 10 January 2017 - Categories: Compliance matters, Good clinical practice, Good distribution practice, Good laboratory practice, Good manufacturing practice, Good pharmacovigilance practice, Inside the Inspectorate, Wider MHRA

In the October blog post we told you about the successful audit of the GMP Inspectorate under the JAP programme. Later that month the entire Inspectorate was assessed as part of the BEMA programme.

Blog MHRA Inspectorate